Capricor Therapeutics
CAPR
#5618
Rank
C$1.98 B
Marketcap
C$34.24
Share price
-0.04%
Change (1 day)
152.69%
Change (1 year)

Capricor Therapeutics (CAPR) - Cash on Hand

Cash on Hand as of March 2026 : C$0.39 Billion

According to Capricor Therapeutics 's latest financial reports the company has C$0.39 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Capricor Therapeutics - Cash on Hand chart (from 2001 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.21 B315.13%
2023-12-31C$52.37 M-6.82%
2022-12-31C$56.2 M26.42%
2021-12-31C$44.45 M6.74%
2020-12-31C$41.65 M222.61%
2019-12-31C$12.91 M30.62%
2018-12-31C$9.88 M-44.34%
2017-12-31C$17.75 M-18.4%
2016-12-31C$21.76 M15.64%
2015-12-31C$18.82 M101.85%
2014-12-31C$9.32 M326.03%
2013-12-31C$2.18 M-49.55%
2012-12-31C$4.33 M310.42%
2011-12-31C$1.05 M-68.7%
2010-12-31C$3.37 M1.06%
2009-12-31C$3.34 M-50.04%
2008-12-31C$6.68 M-58.7%
2007-12-31C$16.19 M
2005-12-31C$0 M-57.11%
2004-12-31C$0 M-45.51%
2003-12-31C$0 M3444.84%
2002-12-31C$0 M-84.11%
2001-12-31C$0 M-98.74%
2000-12-31C$0.01 M
1999-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
C$31.36 B 7,814.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$1.87 B 372.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C$1.16 B 193.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$0.64 B 62.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C$1.81 M-99.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$4.33 M-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA